Health outcomes in offspring born to survivors of childhood cancers following assisted reproductive technologies
Greta Sommerhäuser(Humboldt-Universität zu Berlin), Magdalena Balcerek(University Hospital Leipzig), Ralf Dittrich(Universitätsklinikum Erlangen), Heike Hölling(Robert Koch Institute), Kathy Astrahantseff(Essen University Hospital), Katja Baust(University Hospital Bonn), Theresa Schuster(Humboldt-Universität zu Berlin), Charlotte König(Humboldt-Universität zu Berlin), Laura Lotz(Friedrich-Alexander-Universität Erlangen-Nürnberg), Marta J. Fernández-González(Humboldt-Universität zu Berlin), Anja Borgmann‐Staudt(Humboldt-Universität zu Berlin), Ralph Schilling(Charité - Universitätsmedizin Berlin), Gabriele Calaminus(University Hospital Bonn)
Cited by 16
Related Papers
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|The Lancet Oncology|2016|537
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419
Quality of life and mental health in children and adolescents during the first year of the COVID-19 pandemic: results of a two-wave nationwide population-based study
|European Child & Adolescent Psychiatry|2021|324